Last reviewed · How we verify

NCT05050123

Smartphone-based Virtual Reality Exposure and Standard Relaxation Training for Anxiety on an Inpatient Psychiatric Unit

Terminated NA Last updated 14 August 2023
What this trial tests

NA trial testing iPhone Google Cardboard virtual reality meditation/relaxation app in Anxiety in 10 participants. Terminated before completion.

Timeline
5 October 2021
Primary endpoint
17 December 2021
17 December 2021

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment10
Start date5 October 2021
Primary completion17 December 2021
Estimated completion17 December 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 64, any sex, with Anxiety or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare a smartphone-based virtual reality exposure with standard relaxation training for anxiety and associated symptoms (including pain) on an inpatient psychiatric unit, and whether patients find it usable and beneficial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05050123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing